Free Trial

Ernexa Therapeutics (ERNA) Short Interest Ratio & Short Volume

Ernexa Therapeutics logo
$1.95 -0.03 (-1.52%)
Closing price 07/3/2025 01:36 PM Eastern
Extended Trading
$1.95 0.00 (0.00%)
As of 07/3/2025 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ernexa Therapeutics Short Interest Data

Ernexa Therapeutics (ERNA) has a short interest of 52,200 shares, representing 1.65% of the float (the number of shares available for trading by the public). This marks a -44.05% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 198,347 shares to cover all short positions.

Current Short Interest
52,200 shares
Previous Short Interest
93,300 shares
Change Vs. Previous Month
-44.05%
Dollar Volume Sold Short
$119.54 thousand
Short Interest Ratio
1.0 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
7,360,000 shares
Float Size
3,170,000 shares
Short Percent of Float
1.65%
Today's Trading Volume
29,428 shares
Average Trading Volume
198,347 shares
Today's Volume Vs. Average
15%
Short Selling Ernexa Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Ernexa Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ERNA Short Interest Over Time

ERNA Days to Cover Over Time

ERNA Percentage of Float Shorted Over Time

Ernexa Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202552,200 shares $119.54 thousand -44.1%1.7%1 $2.29
5/31/202593,300 shares $21.00 thousand -26.8%0.5%0.3 $0.23
5/15/2025127,400 shares $29.81 thousand +22.2%0.5%0.7 $0.23
4/30/2025104,300 shares $21.59 thousand -38.6%0.6%0.4 $0.21
4/15/2025169,800 shares $34.01 thousand -19.5%0.9%0.5 $0.20
3/31/2025211,000 shares $37.56 thousand -42.9%1.1%0 $0.18
3/15/2025369,200 shares $94.85 thousand +6.0%1.9%0 $0.26
2/28/2025348,200 shares $105.82 thousand +86.6%1.8%0 $0.30
2/15/2025186,600 shares $57.32 thousand -39.6%0.5%0 $0.31
1/31/2025309,100 shares $116.96 thousand -94.4%0.7%0 $0.38
1/15/20255,490,000 shares $2.39 million +2,178.0%11.2%0.5 $0.44
12/31/2024241,000 shares $70.85 thousand -60.2%0.5%0.3 $0.29
12/15/2024606,200 shares $175.19 thousand +427.1%1.2%0.9 $0.29
11/30/2024115,000 shares $48.88 thousand +142.6%0.2%0.2 $0.43
11/15/202447,400 shares $39.58 thousand +6.5%0.2%0.5 $0.84
10/31/202444,500 shares $48.51 thousand -27.1%1.5%1.4 $1.09
10/15/202461,000 shares $68.32 thousand +12.1%2.2%2.2 $1.12
9/30/202454,400 shares $57.12 thousand +48.6%2.0%2.2 $1.05
9/15/202436,600 shares $54.90 thousand +10.2%1.3%4.1 $1.50
8/31/202433,200 shares $61.49 thousand -10.5%1.2%4.3 $1.85
8/15/202437,100 shares $64.18 thousand -2.4%1.3%4.9 $1.73
7/31/202438,000 shares $68.78 thousand -25.9%1.4%4.1 $1.81
7/15/202451,300 shares $107.22 thousand -5.9%1.8%5.8 $2.09
6/30/202454,500 shares $99.74 thousand -0.9%2.0%7.9 $1.83
6/15/202455,000 shares $105.59 thousand +15.3%2.0%7.7 $1.92
5/31/202447,700 shares $90.63 thousand -9.7%1.7%6.3 $1.90
5/15/202452,800 shares $111.94 thousand +54.4%1.9%5.6 $2.12
4/30/202434,200 shares $62.24 thousand -14.7%1.2%4.1 $1.82
4/15/202440,100 shares $86.22 thousand -5.4%1.4%4.6 $2.15
3/31/202442,400 shares $101.76 thousand +26.2%1.4%4.4 $2.40
3/15/202433,600 shares $73.25 thousand -11.1%1.1%2.7 $2.18
2/29/202437,800 shares $58.97 thousand -74.3%1.3%1.6 $1.56
2/15/2024146,800 shares $233.41 thousand -0.7%4.9%4.8 $1.59
1/31/2024147,900 shares $246.99 thousand +11.7%5.0%4.6 $1.67
1/15/2024132,400 shares $213.16 thousand -1.2%4.4%3.7 $1.61
12/31/2023134,000 shares $240.53 thousand +261.2%4.5%3.9 $1.80
12/15/202337,100 shares $56.02 thousand -67.7%1.2%1.1 $1.51
11/30/2023114,700 shares $103.23 thousand -7.0%3.9%4.3 $0.90
11/15/2023123,300 shares $145.49 thousand +4.2%4.1%9.1 $1.18
10/31/2023118,300 shares $166.79 thousand +6.6%4.0%9.5 $1.41
Post-Halving = Profit Season (Here’s How to Win It) (Ad)

It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.

The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin
10/15/2023111,000 shares $238.87 thousand +1.6%3.7%11.3 $2.15
9/30/2023109,300 shares $238.27 thousand -16.3%3.7%9 $2.18
9/15/2023130,500 shares $315.81 thousand +21.3%4.4%10.2 $2.42
8/31/2023107,600 shares $262.54 thousand +9.9%3.7%8.1 $2.44
8/15/202397,900 shares $237.90 thousand -6.6%3.2%3.7 $2.43
7/31/2023104,800 shares $290.30 thousand -1.5%3.5%3.9 $2.77
7/15/2023106,400 shares $298.98 thousand -1.4%3.6%3.9 $2.81
6/30/2023107,900 shares $239.54 thousand +6.1%3.7%4.4 $2.22
6/15/2023101,700 shares $242.05 thousand -22.1%3.4%4.3 $2.38
5/31/2023130,600 shares $272.95 thousand +64.3%4.5%5.8 $2.09
5/15/202379,500 shares $229.76 thousand No Change2.7%8.6 $2.89

ERNA Short Interest - Frequently Asked Questions

What is Ernexa Therapeutics' current short interest?

Short interest is the volume of Ernexa Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 52,200 shares of ERNA short. 1.65% of Ernexa Therapeutics' shares are currently sold short. Learn More on Ernexa Therapeutics' current short interest.

What is a good short interest ratio for Ernexa Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ERNA shares currently have a short interest ratio of 1.0. Learn More on Ernexa Therapeutics's short interest ratio.

What is a good short interest percentage for Ernexa Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.65% of Ernexa Therapeutics' floating shares are currently sold short.

Is Ernexa Therapeutics' short interest increasing or decreasing?

Ernexa Therapeutics saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 52,200 shares, a decrease of 44.1% from the previous total of 93,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ernexa Therapeutics' float size?

Ernexa Therapeutics currently has issued a total of 7,360,000 shares. Some of Ernexa Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ernexa Therapeutics currently has a public float of 3,170,000 shares.

How does Ernexa Therapeutics' short interest compare to its competitors?

1.65% of Ernexa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ernexa Therapeutics: InflaRx N.V. (2.10%), Avalo Therapeutics, Inc. (0.97%), Oncobiologics, Inc. (12.91%), CervoMed Inc. (4.82%), PMV Pharmaceuticals, Inc. (1.99%), Celularity, Inc. (10.43%), Cue Biopharma, Inc. (1.24%), ImmunoPrecise Antibodies Ltd. (3.50%), bluebird bio, Inc. (2.91%), Renovaro Inc. (5.97%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Ernexa Therapeutics stock?

Short selling ERNA is an investing strategy that aims to generate trading profit from Ernexa Therapeutics as its price is falling. ERNA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ernexa Therapeutics?

A short squeeze for Ernexa Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ERNA, which in turn drives the price of the stock up even further.

How often is Ernexa Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERNA, twice per month. The most recent reporting period available is June, 15 2025.




This page (NASDAQ:ERNA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners